Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IL13 Receptor alpha 1 Antibodies:
anti-Mouse (Murine) IL13 Receptor alpha 1 Antibodies:
anti-Rat (Rattus) IL13 Receptor alpha 1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal IL13 Receptor alpha 1 Primary Antibody for CyTOF, FACS - ABIN4900025
Kajiwara, Shinazawa, Morishima, Yanagihara: Differential effect of IL-4 and IL-13 on the expression of recombination-activating genes in mature B cells from human peripheral blood. in Cellular immunology 2004
Show all 5 Pubmed References
Human Monoclonal IL13 Receptor alpha 1 Primary Antibody for IHC (p) - ABIN1383688
Joshi, Plautz, Puri: Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. in Cancer research 2000
Show all 4 Pubmed References
Human Monoclonal IL13 Receptor alpha 1 Primary Antibody for CyTOF, FACS - ABIN4900024
Bellini, Marini, Bianchetti, Barczyk, Schmidt, Mattoli: Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. in Mucosal immunology 2012
Show all 2 Pubmed References
Human Monoclonal IL13 Receptor alpha 1 Primary Antibody for IHC (p) - ABIN1383689
Andrews, Rosa, Daines, Khurana Hershey: Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity. in Journal of immunology (Baltimore, Md. : 1950) 2001
Human Monoclonal IL13 Receptor alpha 1 Primary Antibody for FACS - ABIN4897070
Biancheri, Di Sabatino, Ammoscato, Facciotti, Caprioli, Curciarello, Hoque, Ghanbari, Joe-Njoku, Giuffrida, Rovedatti, Geginat, Corazza, MacDonald: Absence of a role for interleukin-13 in inflammatory bowel disease. in European journal of immunology 2014
Human Monoclonal IL13 Receptor alpha 1 Primary Antibody for FACS - ABIN4897069
Takenouchi, Hirai, Sakuragi, Yagita, Hamada, Kato: Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts. in Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Human Monoclonal IL13 Receptor alpha 1 Primary Antibody for FACS - ABIN4897071
Kong, Sengupta, Tyler, Bais, Ma, Doucette, Zhou, Sahin, Carter, Brem, Junghans, Sampath: Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. in Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Human Polyclonal IL13 Receptor alpha 1 Primary Antibody for ELISA (Detection), FACS - ABIN4900022
Kohrgruber, Gröger, Meraner, Kriehuber, Petzelbauer, Brandt, Stingl, Rot, Maurer: Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. in Journal of immunology (Baltimore, Md. : 1950) 2004
Human Monoclonal IL13 Receptor alpha 1 Primary Antibody for EIA, FACS - ABIN5540413
Kunii, Nemoto, Kanaya, Tsubahara, Shimauchi: Expression of CD13/aminopeptidase N on human gingival fibroblasts and up-regulation upon stimulation with interleukin-4 and interleukin-13. in Journal of periodontal research 2005
these data suggest that microRNA-143 suppresses IL-13 (show IL13 Antibodies) activity and inflammation through targeting of IL-13Ralpha1 in epidermal keratinocytes
required for induction of the alternative macrophage activation pathway by IL-13 (show IL13 Antibodies) but not by IL-4 (show IL4 Antibodies)
analysis of IL-4 (show IL4 Antibodies) and IL-13 (show IL13 Antibodies) receptors in cancer biology and discussion of pre-clinical and clinical studies pertaining to recombinant immunotoxins designed to target these receptors [review]
review of IL-4 (show IL4 Antibodies) and IL-13 (show IL13 Antibodies) receptor structure, receptor regulation, signaling and experimental therapeutics [review]
Results identified FAM120A (show FAM120A Antibodies) in the IL13 (show IL13 Antibodies)/IL13Ralpha2 signaling pathway as a key mediator of invasion and liver metastasis in colon cancer.
Data show that high expression of interleukin-4 receptor (show IL4R Antibodies) IL-4Ralpha correlated with increased recurrence, while interleukin-13 (show IL13 Antibodies) receptor IL-13Ralpha1 had an inverse relationship to recurrence and survival in oral cavity squamous cell carcinoma patients.
miR (show MLXIP Antibodies)-143 regulation of IL-13 (show IL13 Antibodies)-induced inflammatory cytokine and mucus production in nasal epithelial cells from allergic rhinitis patients probably partly depends on inhibition of IL13Ralpha1.
MiR (show MLXIP Antibodies)-143 may be associated with allergic reaction in human mast cells via downregulation of IL13RA1.
Expression of IL-4 (show IL4 Antibodies), IL-4R, and IL-13R (show IL13RA2 Antibodies) are involved in the process of local metastases in colorectal cancer, while IL-13 (show IL13 Antibodies) expression has an impact on survival.
In Korean asthmatic children, increased serum IgE level was a multi-locus interaction between IL-4Ralpha, IL-13 (show IL13 Antibodies), IL-13Ralpha1, CD14 (show NDUFA2 Antibodies), and CTLA4 (show CTLA4 Antibodies) polymorphisms. The combination of CTLA4 (show CTLA4 Antibodies)/IL-13 (show IL13 Antibodies) and IL-13 (show IL13 Antibodies)/IL-13Ralpha1 polymorphisms showed strong synergistic effects.
These results show that activation of IL-13Ralpha1 is critical for key aspects of the immune and functional responses to Hb2 infection that facilitate expulsion.
These data establish for the first time a molecular mechanism by which Mac-1 (show ITGAM Antibodies) regulates the signaling activity of IL-13 (show IL13 Antibodies) in macrophages.
CAR T cells killed IL13Ra1- and/or IL13Ra2 (show IL13RA2 Antibodies)-positive cells in contrast to IL13Ra1- and IL13Ra2 (show IL13RA2 Antibodies)-negative controls
in neonatal mice, IL-12 (show IL12A Antibodies) uses IL-12Rbeta2 to counter IL-13Ralpha1 expression in addition to promoting Th1 (show HAND1 Antibodies) differentiation
The extracellular and transmembrane domains of the gammaC and interleukin (IL)-13 (show IL13 Antibodies) receptor alpha1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 (show IL4 Antibodies) and IL-13 (show IL13 Antibodies)
IL-13Ralpha1 is the key receptor mediating airway hypersensitivity responses, mucus production, and transforming growth factor (TGF)-beta (show TGFB1 Antibodies) induction in response to aeroallergens.
a central role for the IL-13 (show IL13 Antibodies)/IL-13Ralpha1 pathway in the regulation of intestinal epithelial cell Cl(-) secretion via up-regulation of cystic fibrosis transmembrane conductance regulator (show CFTR Antibodies)
IL-13 (show IL13 Antibodies) and IL-4 (show IL4 Antibodies) via IL-13 (show IL13 Antibodies) receptor alpha1 and the type II IL-4 (show IL4 Antibodies) receptor have direct roles in asthma pathogenesis
The protein encoded by this gene is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4.
, IL-13 receptor subunit alpha-1
, IL-13R subunit alpha-1
, IL13 receptor alpha-1 chain
, bB128O4.2.1 (interleukin 13 receptor, alpha 1)
, cancer/testis antigen 19
, interleukin-13 receptor subunit alpha-1
, interleukin-13-binding protein
, novel cytokine receptor 4
, interleukin 13 receptor alpha 1
, interleukin 13 receptor alpha chain 1
, interleukin 13 receptor, alpha 1
, interleukin-13 receptor subunit alpha-1-like